Rosenberg Matthew Hamilton grew its position in shares of The Sherwin-Williams Company (NYSE:SHW – Free Report) by 45.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 701 shares of the specialty chemicals company’s stock after acquiring an additional 218 shares during the quarter. Rosenberg Matthew Hamilton’s holdings in Sherwin-Williams were worth $241,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also recently bought and sold shares of the company. Brighton Jones LLC raised its stake in shares of Sherwin-Williams by 73.6% during the 4th quarter. Brighton Jones LLC now owns 1,545 shares of the specialty chemicals company’s stock worth $525,000 after purchasing an additional 655 shares during the period. GAMMA Investing LLC raised its stake in shares of Sherwin-Williams by 19.8% during the 1st quarter. GAMMA Investing LLC now owns 4,686 shares of the specialty chemicals company’s stock worth $1,636,000 after purchasing an additional 773 shares during the period. Exchange Traded Concepts LLC raised its stake in shares of Sherwin-Williams by 112.9% during the 1st quarter. Exchange Traded Concepts LLC now owns 477 shares of the specialty chemicals company’s stock worth $167,000 after purchasing an additional 253 shares during the period. Sowell Financial Services LLC bought a new stake in shares of Sherwin-Williams during the 1st quarter worth $306,000. Finally, Inscription Capital LLC bought a new stake in shares of Sherwin-Williams during the 1st quarter worth $216,000. 77.67% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other news, insider Justin T. Binns sold 609 shares of the company’s stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $368.82, for a total transaction of $224,611.38. Following the sale, the insider directly owned 17,922 shares in the company, valued at $6,609,992.04. This represents a 3.29% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CAO James P. Lang sold 860 shares of the company’s stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $350.35, for a total value of $301,301.00. Following the sale, the chief accounting officer owned 377 shares in the company, valued at approximately $132,081.95. This represents a 69.52% decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.60% of the company’s stock.
Sherwin-Williams Trading Down 0.7%
Sherwin-Williams (NYSE:SHW – Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The specialty chemicals company reported $3.38 earnings per share for the quarter, missing the consensus estimate of $3.76 by ($0.38). Sherwin-Williams had a net margin of 11.03% and a return on equity of 66.91%. The company had revenue of $6.31 billion for the quarter, compared to the consensus estimate of $6.31 billion. During the same quarter in the prior year, the company earned $3.70 earnings per share. The company’s quarterly revenue was up .6% on a year-over-year basis. Sherwin-Williams has set its FY 2025 guidance at 11.200-11.500 EPS. On average, equities analysts forecast that The Sherwin-Williams Company will post 12 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on SHW shares. UBS Group reiterated a “buy” rating and set a $400.00 target price (up from $395.00) on shares of Sherwin-Williams in a research note on Monday, October 6th. BMO Capital Markets lowered their target price on Sherwin-Williams from $405.00 to $391.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 23rd. Weiss Ratings restated a “buy (b-)” rating on shares of Sherwin-Williams in a research note on Wednesday, October 8th. Citigroup restated a “neutral” rating and issued a $380.00 price objective (up from $375.00) on shares of Sherwin-Williams in a research note on Monday, October 6th. Finally, Wells Fargo & Company set a $395.00 price objective on Sherwin-Williams and gave the company an “overweight” rating in a research note on Friday, October 10th. One research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $387.13.
View Our Latest Research Report on SHW
About Sherwin-Williams
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Recommended Stories
- Five stocks we like better than Sherwin-Williams
- What is a buyback in stocks? A comprehensive guide for investors
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- What Are the FAANG Stocks and Are They Good Investments?
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Insider Trades May Not Tell You What You Think
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.
